DE SB228

Restores the Delaware Prescription Drug Payment Assistance Program, which was eliminated in Fiscal Year 2018, effective January 1, 2019.

Provides payment assistance up to $3,000 per benefit year for prescription drugs and certain Medicare Part D costs (premiums, deductibles, coverage gaps) to low-income seniors and disabled individuals with income below 200% of Federal Poverty Level or prescription drug expenses exceeding 40% of annual income.

Requires eligible persons to be U.S. citizens or lawfully admitted aliens aged 65+, or ages 19-64 receiving Social Security disability benefits, and to be ineligible for Medicaid and other prescription drug coverage (excluding Medicare Part D).

Establishes a copayment requirement of 5-25% of acquisition cost, restricts covered drugs to those from manufacturers providing rebates, and prohibits direct cash payments to beneficiaries.

Authorizes the Department of Health and Social Services to establish an optional annual enrollment fee not exceeding $20 and to set application periods, quantity limits, and other administrative requirements through regulations.